Pressed by industry lobbyists, White House officials on Wednesday assured drug makers that the administration stood by a behind-the-scenes deal to block any Congressional effort to extract cost savings from them beyond an agreed-upon $80 billion.
White House Affirms Deal on Drug Cost
A respiratory virus that doesn’t have a vaccine or a specific treatment regimen is spreading...
The Supreme Court on March 2 backed parents' right to be told if their child changes...
